Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Impact of Non-Antiretroviral Polypharmacy on the Continuity of Antiretroviral Therapy (ART) Among HIV Patients
Hartmut B. Krentz, M. John Gill
AIDS Patient Care and STDs (2015) Vol. 30, Iss. 1, pp. 11-17
Closed Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

The challenge of HIV treatment in an era of polypharmacy
David Back, Catia Marzolini
Journal of the International AIDS Society (2020) Vol. 23, Iss. 2
Open Access | Times Cited: 146
HIV and ageing
Keri N. Althoff, Mikaëla Smit, Peter Reiss, et al.
Current Opinion in HIV and AIDS (2016) Vol. 11, Iss. 5, pp. 527-536
Open Access | Times Cited: 145
Non-HIV Comorbid Conditions and Polypharmacy Among People Living with HIV Age 65 or Older Compared with HIV-Negative Individuals Age 65 or Older in the United States: A Retrospective Claims-Based Analysis
Amanda M. Kong, Alexis Pozen, Kathryn Anastos, et al.
AIDS Patient Care and STDs (2019) Vol. 33, Iss. 3, pp. 93-103
Open Access | Times Cited: 84
Reorienting health systems to care for people with HIV beyond viral suppression
Kelly Safreed‐Harmon, Jane Anderson, Natasha Azzopardi‐Muscat, et al.
The Lancet HIV (2019) Vol. 6, Iss. 12, pp. e869-e877
Open Access | Times Cited: 76
First occurrence of diabetes, chronic kidney disease, and hypertension among North American HIV-infected adults, 2000-2013
Cherise Wong, Stephen J. Gange, Kate Buchacz, et al.
Clinical Infectious Diseases (2016) Vol. 64, Iss. 4, pp. 459-467
Open Access | Times Cited: 68
Excess Clinical Comorbidity Among HIV-Infected Patients Accessing Primary Care in US Community Health Centers
Kenneth H. Mayer, Stephanie Loo, Phillip M. Crawford, et al.
Public Health Reports (2017) Vol. 133, Iss. 1, pp. 109-118
Open Access | Times Cited: 57
Polypharmacy among HIV positive older adults on anti-retroviral therapy attending an urban clinic in Uganda
Michael Ssonko, Fiona Stanaway, Harriet Mayanja‐Kizza, et al.
BMC Geriatrics (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 30
Prescribing issues in elderly individuals living with HIV
Catia Marzolini, Françoise Livio
Expert Review of Clinical Pharmacology (2019) Vol. 12, Iss. 7, pp. 643-659
Closed Access | Times Cited: 29
Deprescribing of non-antiretroviral therapy in HIV-infected patients
José Ramón Blanco, Ramón Morillo, Vicente Abril, et al.
European Journal of Clinical Pharmacology (2019) Vol. 76, Iss. 3, pp. 305-318
Closed Access | Times Cited: 29
Polypharmacy: a healthcare conundrum with a pharmacogenetic solution
Cierra N. Sharp, Mark W. Linder, Roland Valdes
Critical Reviews in Clinical Laboratory Sciences (2019) Vol. 57, Iss. 3, pp. 161-180
Open Access | Times Cited: 27
Relationship Between Single Tablet Antiretroviral Regimen and Adherence to Antiretroviral and Non-Antiretroviral Medications Among Veterans' Affairs Patients with Human Immunodeficiency Virus
Jenna Yager, John J. Faragon, Liam McGuey, et al.
AIDS Patient Care and STDs (2017) Vol. 31, Iss. 9, pp. 370-376
Closed Access | Times Cited: 25
Ageing with HIV: do comorbidities and polymedication drive treatment optimization?
Lise Cuzin, Christine Katlama, Laurent Cotte, et al.
HIV Medicine (2016) Vol. 18, Iss. 6, pp. 395-401
Open Access | Times Cited: 23
What is polypharmacy in people living with HIV/AIDS? A systematic review
Mohammed Danjuma, Safah Khan, Farah Wahbeh, et al.
AIDS Research and Therapy (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 12
Efficacy and safety of switching to dolutegravir/lamivudine in virologically suppressed people with HIV-1 aged ≥ 50 years: week 48 pooled results from the TANGO and SALSA studies
Sharon Walmsley, Don Smith, Miguel Górgolas, et al.
AIDS Research and Therapy (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 2
Prevalence and global trends of polypharmacy among people living with HIV: a systematic review and meta-analysis
Mohammed Danjuma, Oyelola A. Adegboye, Ahmed Tarek Aboughalia, et al.
Therapeutic Advances in Drug Safety (2022) Vol. 13
Open Access | Times Cited: 11
Multimorbidity With HIV: Views of Community-Based People Living With HIV and Other Chronic Conditions
Jacquelyn Slomka, Maryjo Prince‐Paul, Allison R. Webel, et al.
Journal of the Association of Nurses in AIDS Care (2017) Vol. 28, Iss. 4, pp. 603-611
Open Access | Times Cited: 17
Incidence and Severity of Drug Interactions Before and After Switching Antiretroviral Therapy to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Treatment-Experienced Patients
Jason J. Schafer, Neha Sheth Pandit, Agnes Cha, et al.
Open Forum Infectious Diseases (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 15
A patient-centred approach to deprescribing antiretroviral therapy in people living with HIV
Giovanni Guaraldi, Jovana Milić, Simone Marcotullio, et al.
Journal of Antimicrobial Chemotherapy (2020) Vol. 75, Iss. 12, pp. 3425-3432
Open Access | Times Cited: 15
Real-world medication persistence among HIV-1 patients initiating integrase inhibitor-based antiretroviral therapy in Japan
Xingzhi Wang, Luke Schmerold, Toshio Naito
Journal of Infection and Chemotherapy (2022) Vol. 28, Iss. 11, pp. 1464-1470
Open Access | Times Cited: 9
Comparison of Virological Efficacy of DTG/ABC/3TG and B/F/TAF Regimens and Discontinuation Patterns in Persons Living with Advanced HIV in the Era of Rapid ART: A Retrospective Multicenter Cohort Study
Chun-Yuan Lee, Chen‐Hsiang Lee, Hung-Jen Tang, et al.
Infectious Diseases and Therapy (2022) Vol. 12, Iss. 3, pp. 843-861
Open Access | Times Cited: 8
Immunosenescence and hurdles in the clinical management of older HIV-patients
Marco Ripa, Stefania Chiappetta, Giuseppe Tambussi
Virulence (2017) Vol. 8, Iss. 5, pp. 508-528
Open Access | Times Cited: 14
Polypharmacy and risk of non-fatal overdose for patients with HIV infection and substance dependence
Theresa W. Kim, Alexander Y. Walley, Timothy Heeren, et al.
Journal of Substance Abuse Treatment (2017) Vol. 81, pp. 1-10
Open Access | Times Cited: 14
Effect of Immediate Initiation of Antiretroviral Treatment in HIV-Positive Individuals Aged 50 Years or Older
Sara Lodi, Dominique Costagliola, Caroline Sabin, et al.
JAIDS Journal of Acquired Immune Deficiency Syndromes (2017) Vol. 76, Iss. 3, pp. 311-318
Open Access | Times Cited: 14
Use of Nonantiretroviral Medications That May Impact Neurocognition: Patterns and Predictors in a Large, Long-Term HIV Cohort Study
Kendra K. Radtke, Peter Bacchetti, Kathryn Anastos, et al.
JAIDS Journal of Acquired Immune Deficiency Syndromes (2018) Vol. 78, Iss. 2, pp. 202-208
Open Access | Times Cited: 13
The prevalence of antiretroviral drug interactions with other drugs used in women living with HIV and its association with HIV drug change and patient compliance
Mohammadreza Heydari, Zohre Foroozanfar, Sina Bazmi, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top